You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 121 No. 6, June 2003 TABLE OF CONTENTS
  Archives
  •  Online Features
  Editorial
 This Article
 •Full text
 •PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (3)
 •Contact me when this article is cited
 Related Content
 •Related article
 •Similar articles in this journal
 Topic Collections
 •Cataracts/ Lens
 •Drug Therapy
 •Adverse Effects
 •Alert me on articles by topic
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Does Benzalkonium Chloride Cause Cataract?

Arch Ophthalmol. 2003;121:892-893.

Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

AS ANYONE who has examined a dirty eyedropper bottle retrieved from deep within a patient's pocket or purse knows, the preservatives added to the formulation of antiglaucoma medications play a crucial role in preventing ocular infection among patients receiving long-term therapy. The preservatives must have sufficiently broad spectrum to prevent the growth of bacteria, fungi, and other pathogenic organisms in multidose bottles opened and stored under less than ideal conditions. In many cases, the preservative must remain potent for many months.

The quaternary ammonium compound benzalkonium chloride (BAK) has served our patients well since shortly after mass-produced ophthalmic pharmaceuticals were introduced some 50 years ago. Benzalkonium provided the pharmaceutical industry with an inexpensive, broad-spectrum preservative that had the added benefit of enhancing the penetration of many drugs across the intact cornea. Despite BAK allergy in some patients and concerns about the adverse effect of BAK on the conjunctival epithelium1 (and . . . [Full Text of this Article]



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

RELATED ARTICLE

Human Lens Epithelial Cell Damage and Stimulation of Their Secretion of Chemical Mediators by Benzalkonium Chloride Rather Than Latanoprost and Timolol
Yoko Goto, Nobuhiro Ibaraki, and Kensaku Miyake
Arch Ophthalmol. 2003;121(6):835-839.
ABSTRACT | FULL TEXT  


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Effect of trabeculectomy on lens opacities in an East Asian population.
Husain et al.
Arch Ophthalmol 2006;124:787-792.
ABSTRACT | FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2003 American Medical Association. All Rights Reserved.